Skip to content

Mativ Holdings MATV Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount

Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount at other companies

AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$1.5M-27.0%
CarGurus, Inc. logo
CarGurus, Inc.CARG
$980.25K
ESN
Essent GroupESNT
$79K-61.8%
Vertex, Inc. logo
Vertex, Inc.VERX
$1.13M-8.4%
Bicara Therapeutics logo
Bicara TherapeuticsBCAX
$844.25K
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$330.75K-25.0%

Other financials

Income statement

See full
Revenue$479.6M-1.1%
Gross profit$84.9M+16.9%
Operating income$7.3M+102%
Net income-$11.7M+97.3%
EPS (diluted)-$0.22+97.2%

Balance sheet

See full
Cash & equivalents$87.3M-6.9%
Total debt$1.1B-7.4%
Total equity$472.3M+10.3%
Total assets$2.0B-0.9%

Cash flow

See full
Operating cash flow$1.0M+106%
CapEx$8.4M-39.6%
Free cash flow-$7.4M+75.2%

Valuation

See full
Market cap$440.94M+25.1%
Enterprise value$1.45B+0.5%
P/S0.2×0.0×

Profitability

See full
Gross margin18.9%+1.0pp
Operating margin2.2%+1.1pp
Net margin-22.1%
FCF margin5.9%+4.1pp

Returns & leverage

See full
Return on equity-68.5%
Debt / equity2.3×-0.4×
Current ratio2.3×-0.1×

Where this comes from

Reported directly by Mativ Holdings in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationTaxCreditsResearch.

The official record: Mativ Holdings’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Mativ Holdings's effective income tax rate reconciliation, tax credit, research, amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Mativ Holdings's effective income tax rate reconciliation, tax credit, research, amount?
Mativ Holdings (MATV) reported effective income tax rate reconciliation, tax credit, research, amount of $675K in Q4 2025.
What does effective income tax rate reconciliation, tax credit, research, amount mean?
Represents the absolute dollar value of tax credits claimed by the company for qualified research and development activities. This metric highlights the extent to which the company leverages government incentives to lower its effective tax rate through innovation investment.